Sinopep-Allsino Biopharmaceutical Co Ltd. attended the CPHI Worldwide Frankfurt, Germany

We have been thrilled to participate in the CPHI Worldwide Europe event at the Messe Frankfurt, Germany from November 1st to 3rd 2022. Despite of the difficulties still to travel and attend the exhibition due to the pandemic Covid-19, Sinopep-Allsino Biopharmaceutical Co Ltd. made it a point of honor to be back on the field to meet again face to face with our partners and actively contribute to the health industry's needs, throughout our presence as exhibitor. With +2,500 global exhibitors from +170 countries and roughly 45,000 professionals, Sinopep-Allsino is operating in the CDMO industry for small molecules, peptides and finished dosage forms.

This exhibition is a great opportunity for Sinopep-Allsino's expert team from China, USA, and Europe to explore and meet the customers specifics needs, provide them with the best quality services and share about the company's R&D strength, long expertise in the CDMO from pre-clinical to commercial scale, complying with the Western pharmaceutical requirements with the 2 manufacturing sites located in China. We would like to warmly thank all our customers and suppliers for their unwavering support, their unfailing trust and contribution, making this event successful and productive, as always.

Next after this show, the Sinopep-Allsino's team will join the TIDES EUROPE 2022, the industry's leading event in Europe for oligonucleotides and peptides in Vienna, Austria from November 16th to 18th, 2022, Booth No. 70. Meet you soon in Vienna and next year appointment is the CPHI Barcelona, Spain, we are coming!